CXCL10 and cancer: Interestingly, IFNAR blockade significantly reduced IP-10 responses and reduced T cell responses to the D1-uRNA immunization; this reflected a recent cancer study where anti-IFNAR treatment of unmodified RNA vaccination significantly reduced CD8 T cell responses.38